Results 31 to 40 of about 196,492 (251)

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study

open access: yesRespiratory Research, 2019
Background Evidence on the economic impact of chronic obstructive pulmonary disease (COPD) for third-party payers and society based on large real world datasets are still scarce.
Florian Kirsch   +6 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

The economic burden of atopic dermatitis in Romania: a broad perspective

open access: yesFrontiers in Public Health
IntroductionAtopic dermatitis (AD), a common dermatological condition, is often associated with significant economic and social burdens. Despite extensive studies globally, there is a gap in understanding the impact of this condition in Romania.
Alin Codruț Nicolescu   +7 more
doaj   +1 more source

Indirect costs of bronchial asthma and its complications

open access: yesJournal of Education, Health and Sport, 2019
The study presents an analysis of indirect costs in Poland generated by bronchial asthma, which according to the ICD-10 classification was marked with number J45.
Żaneta Kieliszek   +2 more
doaj   +3 more sources

Economic consequences of caesarean section delivery: evidence from a household survey in Tanzania

open access: yesBMC Health Services Research, 2021
Background Caesarean section (C-section) delivery is an important indicator of access to life-saving essential obstetric care. Yet, there is limited understanding of the costs of utilising C-section delivery care in sub-Saharan Africa. Thus, we estimated
Peter Binyaruka, Amani Thomas Mori
doaj   +1 more source

Indirect Costs and Cost-Effectiveness Analysis

open access: yesValue in Health, 2006
This article examines the methodological implications of the societal perspective in cost-effectiveness analyses in which the costs of health-care interventions are defined as the sums of direct and indirect costs. In the model of cost-effectiveness analysis in which the planner distributes patients among many treatments for many illnesses, the ...
openaire   +2 more sources

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

A Review of Safety Economics Studies and Cost of Occupational Accidents in Iran from 2000 to 2021

open access: yesبهداشت و ایمنی کار, 2022
Introduction: Due to occupational accidents, many costs are annually lost from the countries’ Gross Domestic Product (GDP). Estimating these costs can be essential for optimal investments and establishing appropriate policies in many countries, such as ...
Younes Mehrifar   +6 more
doaj  

Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey

open access: yesBMJ Open, 2020
Objective The prevalence of diabetes in Vietnam has increased from 2.5% in 2007 to 5.5% in 2017, but the burden of direct non-medical and indirect costs is unknown.
Thi Tuyet Mai Kieu   +4 more
doaj   +1 more source

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy